Effect of heparin in the treatment of recurrent IVF–ET Failure
Phase 1
- Conditions
- infertility and IVF failure.female infertility
- Registration Number
- IRCT138807202575N1
- Lead Sponsor
- Shahid Sodoughi Medical Science University, Yazd Research and Clinical Center for Infertility
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion criteria : Pervious failure of IVF cycle at least for three times, age 19-35 years old, BMI = 19- 29, FSH < 10 IU/L, good embryo quality, presence of both ovaries
Exclusion criteria: Presence of PCOS, presence of hydrosalpinx or endometriosis, presence of uterine abnormality, contraindication for heparin, presence of chronic renal, thyroid, or liver diseases, presence of thrombocytopenia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: on day 14 after IVF. Method of measurement: BHCG.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: 2 weeks after positive pregnancy test. Method of measurement: detected of FHR by ultrasound.